Silver-coated carbon nanotubes downregulate the expression of Pseudomonas aeruginosa virulence genes: A potential mechanism for their antimicrobial effect

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 5025-5034

  Dosunmu, Ejovwoke ^a   Chaudhari, Atul A ^a   Singh, Shree R ^a   Dennis, Vida A ^a   Pillai, Shreekumar R ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

AgCNT; Antimicrobial activity; Pseudomonas aeruginosa; qRT PCR

Indexed keywords

GENTAMICIN; POLYMYXIN B; SILVER COATED CARBON NANOTUBE; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL RNA; BIOCOMPATIBLE COATED MATERIAL; CARBON NANOTUBE; SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CELL MEMBRANE INTEGRITY; CELL STRUCTURE; CELLULAR PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPRD GENE; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RPOS GENE; RSMZ GENE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST;

PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DOWN-REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOTUBES, CARBON; PSEUDOMONAS AERUGINOSA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SILVER;

EID: 84939618236     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S85219     Document Type: Article

References (44)

1. Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol. 1997;25(4):279-283.
2. Seo Y, Hwang J, Kim J, Jeong Y, Hwang MP, Choi J. Antibacterial activity and cytotoxicity of multi-walled carbon nanotubes decorated with silver nanoparticles. Int J Nanomedicine. 2014;9:4621-4629.
3. Neelgund GM, Oki A. Deposition of silver nanoparticles on dendrimer functionalized multiwalled carbon nanotubes: synthesis, characterization and antimicrobial activity. J Nanosci Nanotechnol. 2011; 11(4):3621-3629.
4. Valappil SP, Pickup DM, Carroll DL, et al. Effect of silver content on the structure and antibacterial activity of silver-doped phosphate-based glasses. Antimicrob Agents Chemother. 2007;51(12):4453-4461.
5. Nover L, Scharf KD, Neumann D. Cytoplasmic heat shock granules are formed from precursor particles and are associated with a specific set of mRNAs. Mol Cell Biol. 1989;9(3):1298-1308.
6. Terada M, Abe S, Akasaka T, Uo M, Kitagawa Y, Watari F. Multiwalled carbon nanotube coating on titanium. Biomed Mater Eng. 2009; 19(1):45-52.
7. Li Q, Mahendra S, Lyon DY, et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res. 2008;42(18):4591-4602.
8. Yuan W, Jiang GH, Che JF, et al. Deposition of silver nanoparticles on multiwalled carbon nanotubes grafted with hyperbranched poly(amidoamine) and their antimicrobial effects. J Phys Chem C Nanomater Interfaces. 2008;112(48):18754-18759.
9. Eckert R, Brady KM, Greenberg EP, et al. Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother. 2006; 50(11):3833-3838.
10. Van Delden C, Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis. 1998;4(4):551-560.
11. Mendelson MH, Gurtman A, Szabo S, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis. 1994; 18(6):886-895.
12. Delaval M, Boland S, Solhonne B, et al. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia. Part Fibre Toxicol. 2015;12:1.
13. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996;60(3):39-74.
14. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406(6799):959-964.
15. Lodise TP Jr, Patel N, Kwa A, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections s: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51(10):3510-3515.
16. Dunn, M, Wunderink RG. Ventilator-associated pneumonia caused by Pseudomonas infection. Clin Chest Med. 1995;16(1):95-109.
17. Li XZ, Nikaido H, Poole K. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995;39(9):1948-1953.
18. Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol. 2012;302(2):63-68.
19. Balasubramanian D, Schneper L, Merighi M, et al. The regulatory repertoire of Pseudomonas aeruginosa AmpC β-lactamase regulator AmpR includes virulence genes. Plos One. 2012;7(3):e34067.
20. Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother. 1996;40(9):2021-2028.
21. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr. 2007; 19(1):83-88.
22. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005;293(5):581-588.
23. Fegan M, Francis P, Hayward AC, Davis GH, Fuerst JA. Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis. J Clin Microbiol. 1990;28(6):1143-1146.
24. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun. 1980;28(2):546-556.
25. Pier GB, Coleman F, Grout M, Franklin M, Ohman DE. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect Immun. 2001;69(3):1895-1901.
26. Hodges NA, Gordon CA. Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate. Antimicrob Agents Chemother. 1991;35(11):2450-2452.
27. Koch C, Høiby N. Pathogenesis of cystic fibrosis. Lancet. 1993; 341(8852):1065-1069.
28. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M07-A9. 9th ed. Wayne (PA): CLSI; 2012.
29. Peterson LR, Shanholtzer CJ. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev. 1992;5(4):420-432.
30. Clinical and Laboratory Standards Institute. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline M26-A. Wayne (PA): CLSI; 1999.
31. Rangari VK, Mohammad GM, Jeelani S, et al. Synthesis of Ag/CNT hybrid nanoparticles and fabrication of their nylon-6 polymer nanocomposite fibers for antimicrobial applications. Nanotechnology. 2010;21(9):095102.
32. Gooderham WJ, Hancock RE. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev. 2009;33(2):279-294.
33. Pritt B, O’Brien L, Winn W. Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol. 2007;128(1):32-34.
34. Vaez H, Faghri J, Isfahani BN, et al. Efflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals. Adv Biomed Res. 2014;3:117.
35. Khakimova M, Ahlgren HG, Harrison JJ, English AM, Nguyen D. The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance. J Bacteriol. 2013;195(9):2011-2020.
36. Suh SJ, Silo-Suh L, Woods DE, Hassett DJ, West SE, Ohman DE. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol. 1999;181(13): 3890-3897.
37. Zhao K, Li Y, Yue B, Wu M. Genes as early responders regulate quorum-sensing and control bacterial cooperation in Pseudomonas aeruginosa. Plos One. 2014;9(7):e101887.
38. Li K, Xu C, Jin Y, et al. SuhB is a regulator of multiple virulence genes and essential for pathogenesis of Pseudomonas aeruginosa. MBio. 2013;4(6):e00419-13.
39. Sun Z, Shi J, Liu C, et al. PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin. Infect Immun. 2014;82(4):1638-1647.
40. Chemani C, Imberty A, de Bentzmann S, et al. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun. 2009;77(5):2065-2075.
41. Moya B, Dötsch A, Juan C, et al. β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 2009;5(3):e1000353.
42. Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41(1):1-20.
43. Kong KF, Aguila A, Schneper L, Mathee K. Pseudomonas aeruginosa β-lactamase induction requires two permeases, AmpG and AmpP. BMC Microbiol. 2010;10:328.
44. Chaudhari AA, Jasper SL, Dosunmu E, et al. Novel pegylated silver coated carbon nanotubes kill Salmonella but they are non-toxic to eukaryotic cells. J Nanabiotechnology. 2015;13:23.